Q1 2024 Holdings
Filed 2024-05-15 | 15 holdings | $917.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $188.3M | 2,360,077 | 20.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $144.5M | 1,924,626 | 15.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $136.1M | 2,048,647 | 14.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $82.9M | 2,762,837 | 9.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $63.2M | 3,204,841 | 6.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $56.3M | 3,202,798 | 6.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $50.0M | 3,554,129 | 5.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $32.3M | 1,845,813 | 3.5% |
| Merus N V | COM | N5749R100 | $32.3M | 717,254 | 3.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $31.8M | 4,725,641 | 3.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $27.0M | 931,890 | 2.9% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $22.9M | 1,393,329 | 2.5% |
| Geron Corp(GERN) | COM | 374163103 | $22.0M | 6,666,667 | 2.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $14.4M | 378,421 | 1.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $13.4M | 2,040,000 | 1.5% |